Drug Designing: Open Access
Open Access

High Impact List of Articles

• Drug Designing: Open Access
  Probert Chris

  2021 Conference Announcement: Drug Designing: Open Access

• Drug Designing and Development: Emerging Role of Health Technology Assessment
  Anil Vaidya

  Commentary: Drug Designing: Open Access

• The Prodrug Naming Dilemma
  Rafik Karaman

  Editorial: Drug Designing: Open Access

• Virtual Screening Strategies and Application in Drug Designing
  George D Geromichalos

  Editorial: Drug Designing: Open Access

• Drug Discovery with Novel Chemical Libraries
  José L. Medina-Franco

  Editorial: Drug Designing: Open Access

Conference Proceedings

• Fenobam: Old drug, new tricks from serendipity to target-based drug discovery
  Alison Claire Waterfield and L Lindemann

  Scientific Tracks Abstracts: Drug Designing: Open Access

• Fast dissolving drug delivery systems
  Gulay Yelken Demirel

  Scientific Tracks Abstracts: Drug Designing: Open Access

• Design, optimization and characterization of coenzyme Q10 and D-panthenyl triacetate loaded liposomes
  Ali Asram Sag�±roglu, Burak Celik and Samet Ozdemir

  Posters & Accepted Abstracts: Drug Designing: Open Access

• Antibody-proteases as a novel biomarker and a unique target to manage demyelination: A new way for drug design and drug discovery
  Sergey Suchkov, Noel Rose, Aleks Gabibov and Harry Schroeder

  Posters & Accepted Abstracts: Drug Designing: Open Access

• Preclinical drug discovery with patient-specific engineered heart tissues
  Tetsuro Wakatsuki

  Posters-Accepted Abstracts: Drug Designing: Open Access

Relevant Topics in Pharmaceutical Sciences